Point-of-care testing (POCT) continues to play an increasingly important role across UK pathology, supporting faster clinical decision-making, improved patient flow, and more efficient use of healthcare resources. As POCT services expand, Hospitals require solutions that are clinically robust, operationally practical, and aligned with governance and quality frameworks.

Designed for POCT Environments

The FIAPro™ Immunofluorescence Analyser is a high-performance diagnostic instrument for the quantitative/qualitative detection of analytes in whole blood, serum, plasma, urine, and faeces. The system uses advanced LED excitation technology combined with high-sensitivity photoreception to deliver accurate and repeatable results suitable for near-patient testing.

Depending on the assay, results are available in 3 to 15 minutes, supporting timely clinical decisions in settings including:

• * Emergency departments
• *Acute medical and assessment units
• * Outpatient and ambulatory care
• * Community and decentralised testing services
• 
  

The analyser and associated tests meet UK POCT governance requirements, supporting implementation within hospitals quality, safety, and compliance frameworks.

Supporting Multiple Clinical Pathways on a Single Platform

Managing multiple POCT platforms across clinical areas can present challenges for training, oversight, and standardisation. The FIAPro™ system addresses this through a broad and versatile assay menu, enabling multiple pathways to be supported on a single analyser.

The test menu includes but not limited to:

• * Cardiac Markers: hs-cTnI, NT-proBNP, D-dimer
• * Infectious Diseases: Flu A/B, RSV, H. pylori antigen, Malaria (P.f./Pan, P.f./P.v.)
• * Inflammation and Sepsis: Procalcitonin, CRP, hsCRP
• * Endocrinology: TSH, FT3, FT4, AMH, Cortisol
• * Diabetes and Renal Monitoring: HbA1c, Microalbumin, Cystatin C
• * Nutrition and Anaemia: Vitamin D, Folic Acid, Ferritin
• * Oncology Screening: FOB, CA125
• 
  

This breadth supports platform consolidation, simplified operator training, and improved governance oversight for POCT services.

• Operational Benefits for Hospital Services

  Beyond rapid turnaround times, POCT systems must deliver measurable operational value. The FIAPro™ Immunofluorescence Analyser is designed to support:

  • * Faster rule-in and rule-out decisions in acute care
  • * Improved patient flow and reduced length of stay
  • * Reduced reliance on central laboratory turnaround times
  • * Greater flexibility in community and decentralised care models
  • * Standardisation of POCT across multiple clinical areas
  • 
    

  The compact design and intuitive operation support deployment in space-constrained clinical environments

• 
  

Further Information

For further information on the FIAPro™ Immunofluorescence Analyser, including assay availability, governance documentation, or discussions with POCT and pathology teams:

📧 info@sussexbiologicals.co.uk